Hehenkamp WJK

No ORCID on file · 12 papers in corpus
observational 2026
PloS one ·doi:10.1371/journal.pone.0345619

OBJECTIVE: To evaluate whether the COVID-19 pandemic influenced treatment modality, care intensity, and care setting in benign gynecological care in the Netherlands. DESIGN: Retrospective longitudinal cohort study evaluating the effects of…

review 2025
Therapeutics and clinical risk management ·doi:10.2147/tcrm.s273358

INTRODUCTION: Ulipristal acetate (UPA, 5 mg) demonstrated efficacy in symptom reduction for patients with symptomatic fibroids. While registration and post-marketing trials assessing UPA identified few hepatic concerns, post-marketing conce…

rct 2025
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.15165

INTRODUCTION: Uterine artery embolization (UAE) is a less-invasive alternative for hysterectomy in therapy-resistant symptomatic adenomyosis. Comparative data are lacking. Our objective is to evaluate the non-inferiority of UAE compared wit…

observational 2025
BMJ open ·doi:10.1136/bmjopen-2025-100357

OBJECTIVE: To examine the impact of the COVID-19 pandemic on the substitution of surgical procedures in benign gynaecology in the Netherlands. DESIGN: Quantitative longitudinal study evaluating the effects of the COVID-19 pandemic. SETTIN…

other 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14914

INTRODUCTION: Imaging fibroid vascularity may predict fibroid growth and aid to determine most appropriate therapy. Microvascular (MV) flow imaging is relatively new and is able to detect slow flow in small vessels. Data on feasibility, rep…

observational 2024
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14844

INTRODUCTION: Many women experience bleeding disorders that may have an anatomical or unexplained origin. Although hysterectomy is the most definitive and common treatment, it is highly invasive and resource-intensive. Less invasive therapi…

guideline 2024
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.16.3.036

BACKGROUND: Uterine niches in the Caesarean section scar are seen in approximately half of women with a history of caesarean delivery. Whilst a structured ultrasound assessment of caesarean defects has been described, there is no consensus …

other 2023
BMJ open ·doi:10.1136/bmjopen-2022-070950

INTRODUCTION: A uterine niche is a defect at the site of the uterine caesarean scar that is associated with gynaecological symptoms and infertility. Promising results are reported in cohort studies after a laparoscopic niche resection conce…

meta-analysis 2023
International journal of molecular sciences ·doi:10.3390/ijms24087011

Uterine fibroids are the most common benign tumors in women, with abnormal uterine bleeding (AUB) as the main reported symptom. Additionally, an association between fibroids and infertility has been established, especially if the fibroid pr…

observational 2023
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14647

INTRODUCTION: After incomplete healing of the uterine cesarean section scar, a niche can be observed; 24% of the women develop large niches with a residual myometrial thickness <3 mm. In these cases a laparoscopic resection is possible. The…

observational 2021
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.13.4.044

BACKGROUND: Uterine fibroids present differently, from well vascularised up to calcified, with some causing heavy menstrual bleeding (HMB). OBJECTIVES: To investigate the association between fibroid vascularisation and HMB, other fibroid r…

observational 2019
CVIR endovascular ·doi:10.1186/s42155-019-0061-5

BACKGROUND AND PURPOSE: The Dutch national guideline on heavy menstrual bleeding was updated and published in 2013. It recommended (for the first time) that uterine artery embolization (UAE) should be part of counseling of women with sympto…